UPDATES
PREDICT-Meso Newsletter links
click here for links to all PREDICT-Meso Newsletters to date (Apr24)
Publication- Crosstalk with lung fibroblasts shapes the growth and therapeutic response of mesothelioma cells
PREDICT-Meso Co-I Daniel J. Murphy co-authoured a paper accepted for publication in Cell Death and Disease, with Olivier E. Pardo and Yakinthi Chrisochoidou at Imperial. This work was carried out as part of WP4- Target Drug Validation Abstract Mesothelioma is an aggressive cancer of the...
Publication- Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance
click here for link to full text
Publication- Asbestos accelerates disease onset in a genetic model of malignant pleural mesothelioma
click here for link to full text
PREDICT-Meso pre-clinical models school
Pre-clinical models school
iMig 2023
PREDICT-Meso at iMig 2023
PREDICT-MESO NEWSLETTER #2 JULY 2023
Click here to access PREDICT-Meso Newsletter #2 July23
Meso-ORIGINS UPDATE MAY 2023
Meso-ORIGINS has been open for 11 months now and things are going well. We now have 14 Health Boards/Trusts open, with 15 hospitals taking part across these 14 sites. NHS Greater Glasgow and Clyde (NHSGGC)- Queen Elizabeth University Hospital; Glasgow Royal Infirmary; Gartnavel General Hospital...
Applications for the Mesothelioma UK 2023 funding grant are now open
Up to £40,000 of grant funding is available
PREDICT-Meso Newsletter – April 2023
Click here for access to the first PREDICT-Meso Newsletter
EVENTS
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.